Chesapeake Financial Shares Inc
Change company Symbol lookup
Select an option...
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc
HD Home Depot Inc
ACPS AC Partners Inc
FONR Fonar Corp
WBRRFX BlackRock Russell 2000 Growth Index Fund
WSM Williams-Sonoma Inc
BLK BlackRock Inc

Financials : Banks |
Company profile

Chesapeake Financial Shares, Inc. (CFS) is a bank holding company. The Company has interest in Chesapeake Bank (the Bank), Chesapeake Investment Group, Inc. (CIG) and CFS Capital Trust (the Trust). The Bank offers mortgage, commercial and consumer loans to its customers. Its loan portfolio includes commercial loans, such as non-real estate, commercial-real-estate, consumer-non real estate and residential real estate. It offers personal and business products and services, including checking, savings, certificates of deposit, mortgages, mobile and online banking, e-services comprising an Internet branch, and a business cash management program. Its securities available for sale include securities of state and political subdivisions, and mortgage-backed securities. CIG offers brokerage, trust and estate management services.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Insights on the Rapid Medical Diagnostic Kits Global Market to 2027 - Featuring Abbott Laboratories, Beckman Coulter & bioMerieux Among Others -

12:18 pm ET September 22, 2020 (BusinessWire) Print

The "Rapid Medical Diagnostic Kits - Global Market Trajectory & Analytics" report has been added to's offering.

The publisher brings years of research experience to the 7th edition of this report. The 288-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Rapid Medical Diagnostic Kits Market to Reach $34 Billion by 2027

Amid the COVID-19 crisis, the global market for Rapid Medical Diagnostic Kits estimated at US$24.9 Billion in the year 2020, is projected to reach a revised size of US$34 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027.

Hospitals and Clinics, one of the segments analyzed in the report, is projected to record a 4.4% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Home Healthcare segment is readjusted to a revised 4.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 7% CAGR

The Rapid Medical Diagnostic Kits market in the U.S. is estimated at US$6.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Veterinary Segment to Record 3.5% CAGR

In the global Veterinary segment, USA, Canada, Japan, China and Europe will drive the 3.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$929.1 Million in the year 2020 will reach a projected size of US$1.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.5 Billion by the year 2027, while Latin America will expand at a 4.4% CAGR through the analysis period.

Competitors identified in this market include, among others:

Abbott Laboratories Alfa Scientific Designs, Inc. Arkray USA, Inc. Beckman Coulter, Inc. Becton, Dickinson and Company Biomerica, Inc. bioMerieux SA Bio-Rad Laboratories, Inc. Diagnostic Automation / Cortez Diagnostics, Inc. EKF Diagnostics Holdings PLC Enzo Life Sciences, Inc. F. Hoffmann-La Roche AG Idexx Laboratories, Inc. InBios International Jant Pharmacal Corporation Labsystems Diagnostics Oy LifeScan, Inc. Princeton BioMeditech Corporation Quidel Corporation Rapid Diagnostics Pvt., Ltd. Roche Diagnostics Runhe Biomedical Technology (Shantou) Co., Ltd. SA Scientific Sekisui Diagnostics LLC Shanghai Kehua Bio-engineering Co., Ltd. Siemens Healthineers TaiDoc Technology Corporation Thermo Fisher Scientific, Inc. Zoetis, Inc.

Key Topics Covered:




Global Competitor Market Shares Rapid Medical Diagnostic Kits Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of COVID-19 and a Looming Global Recession






Total Companies Profiled: 42

For more information about this report visit

View source version on

SOURCE: Research and Markets
Laura Wood, Senior Press Manager 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.